Covidien Ltd. (NYSE:COV)

CAPS Rating: 5 out of 5

The Company is in the business of developing, manufacturing and distributing medical devices and supplies, diagnostic imaging agents, pharmaceuticals and other healthcare products for use in clinical and home settings.

Results 1 - 20 of 47 : 1 2 3 Next »

Recs

0
Member Avatar bizcbug7 (75.37) Submitted: 4/14/2014 2:14:42 PM : Outperform Start Price: $69.71 COV Score: -1.89

Innovative company, increased focused R&D from 2% to 4.9% of revenues. Sold off pharma, so YoY sales comps will start to look better in 4th Q of 2014.

Recs

0
Member Avatar smmart2 (< 20) Submitted: 11/14/2013 5:10:17 PM : Outperform Start Price: $65.47 COV Score: +2.91

Recent spin-off allows the company to focus on core growthing business.
Strong cash flow and clear strategy on return of capital to shareholders.

Recs

0
Member Avatar CMCassociates (34.13) Submitted: 11/7/2013 8:10:16 PM : Outperform Start Price: $61.44 COV Score: +7.11

From the value investor's perspective, Covidien stands out as a reliably impressive performer considering its ROE, ROA, 5 year trailing earnings growth, and quick ratio. COV's ROE is consistently quite attractive.

Recs

0
Member Avatar joncremeans (60.00) Submitted: 1/29/2013 2:51:58 PM : Outperform Start Price: $61.79 COV Score: -10.74

Spinoff

Recs

0
Member Avatar BrentonKJ (20.70) Submitted: 10/13/2012 2:28:14 PM : Outperform Start Price: $53.44 COV Score: -1.62

Great management. Good PE and solid dividend. Investing heavily in R and D.

Recs

0
Member Avatar tomd728 (< 20) Submitted: 10/4/2012 9:50:53 AM : Outperform Start Price: $57.97 COV Score: -7.50

In the forefront of developing,acquiring,marketing and execution....

What else you want ? The COV team is doing all the
right moves to bring COV higher with respectable P:E:,P:S,Cash Flow (after cap ex).

Recs

0
Member Avatar evanjfried (< 20) Submitted: 7/26/2012 11:19:09 PM : Outperform Start Price: $52.09 COV Score: -2.04

The public needs training in their ability to evaluate stocks as per experience.

Recs

0
Member Avatar MrMilken (< 20) Submitted: 7/9/2012 12:32:32 PM : Outperform Start Price: $51.36 COV Score: -2.67

Good management, favorable environment.

Recs

0
Member Avatar jermskirk (85.14) Submitted: 5/25/2012 1:11:14 PM : Outperform Start Price: $51.71 COV Score: -5.73

More growth, higher margins post spin-off of pharma

Recs

1
Member Avatar ceejayoh (71.23) Submitted: 12/30/2011 7:15:32 AM : Outperform Start Price: $42.99 COV Score: +15.73

Picked on the recommendation of TMFdeej

Recs

0
Member Avatar TMFDeej (99.46) Submitted: 12/15/2011 7:31:35 PM : Outperform Start Price: $42.03 COV Score: +13.72

Covidien is a company that I've had my eye on for a while, ever since it was spun off from Tyco. It hasn't done much but bounce around since then. It just announced that it plans to split its medical device and pharma businesses. I like the move.

Deej

Recs

0
Member Avatar doctorfool1 (< 20) Submitted: 8/19/2011 11:47:37 AM : Outperform Start Price: $45.81 COV Score: -11.49

Baby Boomers.

Recs

0
Member Avatar FrancineT (< 20) Submitted: 5/23/2011 1:19:56 PM : Outperform Start Price: $52.68 COV Score: -8.71

Mechanical formula YLDEARNYEAR2

Recs

0
Member Avatar stovkey1highdiv (< 20) Submitted: 5/12/2011 9:58:29 AM : Outperform Start Price: $52.52 COV Score: -6.50

key03, 1.4% annual dividend

Recs

1
Member Avatar CellBlock9 (93.40) Submitted: 3/13/2011 9:25:22 PM : Outperform Start Price: $49.49 COV Score: -2.22

s&P 5 star. 1.4 div

Recs

0
Member Avatar Superannuation (45.28) Submitted: 12/30/2010 11:52:36 PM : Outperform Start Price: $42.82 COV Score: +14.66

50 crossing 200 strong fundamentals

Recs

0
Member Avatar DeadmanLiving (71.46) Submitted: 12/9/2010 3:02:11 PM : Outperform Start Price: $40.76 COV Score: +21.04

Raymond James Picks 2011

Recs

0
Member Avatar bobabushka (68.54) Submitted: 10/27/2010 10:45:32 AM : Outperform Start Price: $37.89 COV Score: +25.85

Growth in 5 to 10 years. Probably longer. Medical devices medical devices medical devices... we'll all be needing them and they're leading the niche markets, sopping up whatever they can that looks valuable.

Recs

0
Member Avatar MizzouFanVan (92.79) Submitted: 10/25/2010 2:05:48 PM : Outperform Start Price: $37.86 COV Score: +27.97

Stock Picker - 5 Star, Pays Dividend, Down at Least 20% over last 12 months

Recs

0
Member Avatar 21popsontop (< 20) Submitted: 10/4/2010 3:23:03 PM : Outperform Start Price: $37.50 COV Score: +22.38

Has the look of value

Results 1 - 20 of 47 : 1 2 3 Next »

Featured Broker Partners


Advertisement